In this study, we were not able to detect any differences in tumor growth between the TB and MR16-1 groups (Table 1), and there was no correlation between tumor volume and human IL-6 levels (data not shown), suggesting that amelioration of cancer-related symptoms was not due to regression of tumors in the LC-06-JCK model. The gene discussed is IL6; the disease is cancer.